Insmed INSM Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$1.28B-39.7% | -$913.77M-21.9% | -$749.57M-55.7% | -$481.53M-10.8% | ||
| $10.45M+75.3% | $5.96M+7.9% | $5.53M+4.7% | $5.28M-42.2% | ||
| $152.71M+57.7% | $96.84M+29.5% | $74.78M+29.6% | $57.69M+25.3% | ||
| $6.22M-9.7% | $6.88M-6.0% | $7.32M+83.4% | $3.99M— | ||
| $88.31M+583% | $12.93M+8.1% | $11.96M— | —— | ||
| $31.52M+84.9% | $17.04M+25.2% | $13.61M— | —— | ||
| $100.07M+124% | $44.59M+194% | $15.16M-69.7% | $50.01M— | ||
| $2.12M— | —— | $20.07M-27.7% | $27.75M+6.5% | ||
| -$4.99M+58.2% | -$11.95M-8.7% | -$10.99M— | —— | ||
| $20.68M+3.1% | $20.04M+6.4% | $18.85M+411% | $3.69M— | ||
| $6M+18.8% | $5.05M0.0% | $5.05M0.0% | $5.05M0.0% | ||
| $251.99M— | —— | $28.7M+238% | -$20.8M— | ||
| -$935.01M-36.7% | -$683.88M-27.5% | -$536.25M-33.9% | -$400.44M-10.2% | ||
| $32.56M+48.5% | $21.92M+65.0% | $13.29M+34.5% | $9.88M+35.5% | ||
| $2.09B— | —— | $375M+400% | $75M— | ||
| —— | —— | —— | —— | ||
| —— | $1.08B+611% | $152.48M-47.8% | $292.15M— | ||
| $2.96M+13.4% | $2.61M— | —— | —— | ||
| $954.07M-28.9% | $1.34B+696% | $168.44M-78.8% | $793.27M+29.5% | ||
| —— | -$1.31M— | —— | -$996K-6.8% | ||
| —— | $72.66M+112% | -$591.66M-266% | $357.25M— | ||
| $55.35M+36.4% | $40.57M+13.4% | $35.79M+252% | $10.16M-6.7% | ||
| $4.14M+65.7% | $2.5M+27.8% | $1.96M+13.9% | $1.72M+10.2% | ||
| $6.22M-9.7% | $6.88M-6.0% | $7.32M+83.4% | $3.99M— | ||
| $6M+18.8% | $5.05M0.0% | $5.05M0.0% | $5.05M0.0% | ||
| $251.99M— | —— | $28.7M+238% | -$20.8M— | ||
| $10.45M+75.3% | $5.96M+7.9% | $5.53M+4.7% | $5.28M-42.2% | ||
| $53.43M— | —— | -$2.27M— | —— | ||
| $9.65M— | —— | $9.21M-23.1% | $11.98M-4.9% | ||
| —— | $0— | $0— | —— | ||
| $2.96M+13.4% | $2.61M— | —— | —— | ||
| $2.71M0.0% | $2.71M0.0% | $2.71M+38.4% | $1.96M+81.8% | ||
| $4.14M+65.7% | $2.5M+27.8% | $1.96M+13.9% | $1.72M+10.2% | ||
| -$967.58M-37.1% | -$705.81M-28.4% | -$549.54M-33.9% | -$410.32M-10.7% | ||
| -$967.58M-37.1% | -$705.81M-28.4% | -$549.54M-33.9% | -$410.32M-10.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Insmed generate?
- Insmed (INSM) generated -$895.7M in operating cash flow over the trailing twelve months.
- What is Insmed's free cash flow?
- After $26.0M of capital expenditures, Insmed's free cash flow was -$921.6M over the trailing twelve months, down 16.8% year over year.
- Where does Insmed's cash flow data come from?
- Every line is extracted from Insmed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
